Trials / Unknown
UnknownNCT05449873
No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet Electrodes
No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Locoregional Treatment Using Combined Energy Delivery Mode and Triple Cooled-Wet Electrodes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate local tumor progression rate at 12 months after no-touch percutaneous radiofrequency ablation using combined energy delivery mode and triple cooled electrodes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radiofrequency ablation using combined bipolar and monopolar energy deliver with Triple Cooled-Wet electrodes | Radiofrequency ablation will be performed by using triple cooled-wet electrodes. Two or three electrodes will be places around the tumor under ultrasonography (US)-computed tomography (CT)/magnetic resonance (MR) fusion tool guidance. The electrodes will be cooled with saline, and radiofrequency (RF, bipolar mode and switching monopolar mode) will be applied to two of three electrodes at the same time for about 6 to 30 minutes depending on the tumor size. The temperature will be maintained at 90-100 °C. |
Timeline
- Start date
- 2021-10-18
- Primary completion
- 2023-07-30
- Completion
- 2023-07-30
- First posted
- 2022-07-08
- Last updated
- 2022-10-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05449873. Inclusion in this directory is not an endorsement.